CEACAM5 and breast cancer: No preclinical study of CAR-T cells for BC has targeted the serum tumor marker carcinoembryonic antigen (CEA), while a clinical trial of CAR-T cell therapy targeting CEA to remedy BC subjects is underway (NCT04348643) (Fig. 3).